These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 4164146)
21. Mechanisms of tumor homograft rejection. II. Studies on the mechanism of rejection of sarcoma I ascites tumor in the C57BL-Ks mouse. Holmes B; Weiser RS J Natl Cancer Inst; 1966 May; 36(5):975-83. PubMed ID: 5939584 [No Abstract] [Full Text] [Related]
22. Cell-mediated cytotoxicity: an assay using 125 I-iododeoxyuridine-labeled target cells. Cohen AM; Burdick JF; Ketcham AS J Immunol; 1971 Sep; 107(3):895-8. PubMed ID: 5572095 [No Abstract] [Full Text] [Related]
23. Possible detection of presensitization to donor alloantigens by immunofluorescence. Ablin RJ Nephron; 1974; 13(3):230-4. PubMed ID: 4138506 [No Abstract] [Full Text] [Related]
24. ISOANTIGENIC PROPERTIES OF TUMORS TRANSGRESSING HISTOCOMPATIBILITY BARRIERS OF THE H-2 SYSTEM. MOELLER E J Natl Cancer Inst; 1964 Dec; 33():979-89. PubMed ID: 14241790 [No Abstract] [Full Text] [Related]
26. [Methodical problems in demonstration of heterologous and homologous circulating antibodies of the kidney]. Tacke A; Schneeweiss B; Erdmann T Acta Biol Med Ger; 1971; 26(1):151-63. PubMed ID: 5577785 [No Abstract] [Full Text] [Related]
27. Basic proteins and synthetic polynucleotides as modifiers of immunogenicity of syngeneic tumor cells. Braun W; Plescia OJ; Raskova J; Webb D Isr J Med Sci; 1971 Jan; 7(1):72-82. PubMed ID: 4100526 [No Abstract] [Full Text] [Related]
28. Evidence for the IgG nature of complement-fixing (CF) antibodies to adenovirus type 12 hamster tumor neoantigens. Van Hoosier GL; Cupp C; Boren D; Trentin JJ J Immunol; 1968 Jan; 100(1):128-32. PubMed ID: 4169692 [No Abstract] [Full Text] [Related]
29. Immunological enhancement of sarcoma I by antibody to fetal antigens in syngeneic mice. Goldberg EH; Tokuda S Transplantation; 1976 Mar; 21(3):263-5. PubMed ID: 941214 [No Abstract] [Full Text] [Related]
31. [Role of nonspecific globulins in the biosynthesis of antibodies]. Prokopenko LG Biull Eksp Biol Med; 1966 Apr; 61(4):77-80. PubMed ID: 4193737 [No Abstract] [Full Text] [Related]
32. Induction of antibody synthesis. Effect of blocking defined determinants of an antigen. Bernardini A; Imperato S; Plescia OU Immunology; 1970 Feb; 18(2):187-201. PubMed ID: 4190417 [TBL] [Abstract][Full Text] [Related]
35. Regulation of immunity toward allogeneic tumors in mice. II. Effect of antiserum and antiserum fractions on cellular and humoral response. Takasugi M; Hildemann WH J Natl Cancer Inst; 1969 Oct; 43(4):857-67. PubMed ID: 5344182 [No Abstract] [Full Text] [Related]
36. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO. WARD PA; COCHRANE CG; MUELLER-EBERHARD HJ J Exp Med; 1965 Aug; 122(2):327-46. PubMed ID: 14316948 [TBL] [Abstract][Full Text] [Related]
37. Homograft inhibition by competing protein antigens in inbred mice. Miller J; Glenn WL Surg Forum; 1965; 16():237-9. PubMed ID: 4158119 [No Abstract] [Full Text] [Related]
38. Immunosuppression versus immunity in syngeneic and allogeneic tumours. Vlachov K; Nouza K Neoplasma; 1973; 20(1):3-12. PubMed ID: 4573871 [No Abstract] [Full Text] [Related]
39. Inhibition of cellular immunity and enhancement of humoral antibody formation in mice infected with lactic dehydrogenase virus. Howard RJ; Mergenhagen SE; Notkins AL; Dougherty SF Transplant Proc; 1969 Mar; 1(1):586-8. PubMed ID: 4109228 [No Abstract] [Full Text] [Related]
40. [Origin of effector and rosette-forming cells in transplantation immunity in mice]. Brondz BD; Kotomina IF Biull Eksp Biol Med; 1973 Sep; 76(9):69-72. PubMed ID: 4130411 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]